INVESTMENT IN IMAGION BIOSYSTEMS

9 Months Ended

Sep. 30, 2022

INVESTMENT IN IMAGION BIOSYSTEMS

NOTE 3 - INVESTMENT IN IMAGION BIOSYSTEMS

NOTE 3 – INVESTMENT IN IMAGION BIOSYSTEMS

As of September 30, 2022, the Company owns 51,766,508 shares of Imagion, resulting in a non-controlling interest of Imagion’s issued and outstanding common stock. Based upon Imagion’s trading price on September 30, 2022, approximately $0.03 per share, the fair value of the Imagion shares was approximately $1,064,000. During the nine months ended September 30, 2022, the Company recorded a loss on fair value in its investment of $1,809,000.

Below is reconciliation for the changes to the investment in Imagion for the nine months ended September 30, 2022:

Balance as of December 31, 2021	$	2,901,000
Change due to the sale of securities		(28,000	)
Change in the unrealized fair value of securities		(1,809,000	)
Balance as of September 30, 2022	$	1,064,000